Sameena Rahman, MD, discusses how digital symptom trackers can shorten PMOS diagnostic delays and support earlier cardiometabolic care.
|Articles|January 24, 2012
Poll: Should Drug Companies Disclose Payments They Make to Doctors?
Author(s)OBGYN.net Staff
The Obama administration is considering requiring drug companies to disclose all payments they make to doctors. This would include funds for research, speaking engagements, consulting, entertainment, etc.
Advertisement
The Obama administration is considering requiring drug companies to disclose all payments they make to doctors. This would include funds for research, speaking engagements, consulting, entertainment, etc.
Advertisement
Related to this article
A new, expert-led video series explores the PCOS-to-PMOS rename and what it means for diagnosis, care, and outcomes.
Seventy-one percent of women miss their first perimenopausal symptom because anxiety, brain fog, and mood changes precede hot flashes—and most attribute them to stress, per the Bonafide 2026 State of Menopause Survey.
A real-world study presented at Psych Congress found that zuranolone's PPD symptom improvements were sustained through day 90.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.
A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
Hugh Taylor, MD, explains that imaging in endometriosis is best for ruling out other causes of pelvic pain and cannot exclude the diagnosis.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Zuranolone shows sustained PPD symptom improvement through day 90
2
Emotional and cognitive symptoms are redefining perimenopause recognition
3
Survey: 51% of US-women report negative healthcare experiences
4
Q&A: Sameena Rahman, MD, on digital symptom tracking in PMOS
5